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ABSTRACT Dynemicin is a hybrid containing anthraqui-
none and enediyne cores, which contribute to binding and
cleavage of DNA, respectively. DNA strand scission by the
antitumor antibiotic is significantly enhanced by the addition of
NADPH or thiol compounds. The preferential cutting site of
dynemicin is on the 3' side of purine bases (i.e., 5'-GC, -GT,
and -AG) and is clearly different from the cutting sites of
esperamicin and calicheamicin. The double-stranded and the
stem regions of single-stranded DNAs are preferentially
cleaved by dynemicin. Therefore, dynemicin may be a useful
reagent for probing secondary structures of DNA. Pretreat-
ment of DNA with Adriamycin and actinomycin D alters the
cutting mode of dynemicin. Dynemicin-mediated DNA break-
age is strongly inhibited by pretreatment of the DNA with
distamycin A and anthramycin, suggestng that dynemicin
interacts with the minor groove of the DNA helix. Intercalation
of the anthraquinone core into the DNA followed by the attack
of the phenyl diradical formed from the enediyne core is
considered as a possible mechanism of action of dynemicin.
Dynemicin, isolated from the fermentation broth of Mi-
cromonospora chersina, possesses potent cytotoxicity and in
vivo antitumor activity (1). This antibiotic is a hybrid mole-
cule of two typical chemotypes of antitumor agent, enediyne
and anthraquinone (Fig. 1). Esperamicin, calicheamicin, and
neocarzinostatin, which produce DNA strand breaks, belong
to the family of enediyne antitumor antibiotics (2-5). DNA
cleavage by esperamicin and calicheamicin appears to in-
volve rearrangement of the enediyne unit, a phenylene dirad-
ical that can abstract hydrogen atoms from the sugar phos-
phate backbone of DNA. On the other hand, daunomycin,
Adriamycin, and aclacinomycin belong to the class of an-
thracycline antitumor antibiotics and can intercalate into
DNA through the planar aromatic rings (6, 7). Indeed, an
x-ray diffraction study (8) demonstrated that two daunomy-
cin molecules intercalate between the GC base pairs in the
self-complementary hexanucleotide CGTACG. Evidently,
dynemicin possesses these two structural features in one
molecule and hence we were interested in clarifying the
mechanism through which dynemicin cleaves DNA.
MATERIALS AND METHODS
Drugs and Chemicals. Dynemicin was isolated from the
fermentation broth of Micromonospora chersin and purified
as described (1). Esperamicin A1 and anthramycin were a
generous gift of T. W. Doyle (Bristol-Myers) and L. H.
Hurley (University of Texas), respectively. Adriamycin and
distamycin A were offered by F. Arcamone (Farmitalia).
Plasmid pBR322 DNA was isolated from Escherichia coli
C600, and restriction enzymes, such as EcoRI, Sal I, and Dra
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FIG. 1. Chemical structures of dynemicin (Left) and its aroma-
tized derivative (Right). This aromatic compound was obtained by
treating dynemicin with HCl and its structure was identified by NMR
and x-ray crystallographic methods.
II, were obtained from Takara Shuzo (Kyoto, Japan). Stem-
and-loop structure G4DNA obtained from phage R199/G4ori
replicative form DNA was a kind gift of T. Komano (Kyoto
University, Japan). Ethidium bromide, actinomycin D, and
NADPH were purchased from Sigma. All other chemicals
used were of commercial reagent grade.
Assay for DNA Cleavage Activity. Analysis of drug (5
,uM)-induced damage to supercoiled, covalently closed, cir-
cular (form I) pBR322 DNA was performed in the presence
of NADPH, dithiothreitol, 4-hydroxythiophenol, or NaBH4
(compound used was added at 5 AM-100 mM) for 30 min-24
hr at 37TC, followed by agarose gel electrophoresis to sepa-
rate the various DNA products-namely, nicked relaxed
circular DNA (form II) and linearized DNA (form III). DNA
bands were visualized by using ethidium bromide binding and
UV illumination.
Nucleotide Sequence Analysis. The reaction samples (total
volume, 50 Al) contained a 5'-end-labeled 70-base-pair (bp)(EcoRI-Dde I) fragment or a 128-bp (Sal I-Dra II) pBR322
DNA fragment, sonicated calf thymus carrier DNA (20
,ug/ml), and 10 mM Tris-HCl buffer (pH 7.5). Nucleotide
sequence cleavage was initiated by addition of dynemicin
(5-50 AM) and NADPH (5 mM) or dithiothreitol (5 mM), and
then the samples were incubated at 370C for 5 hr. Cleavage
experiments for the complementary strand (3'-32P-labeled
DNA) were carried out by using the Sal I-Dra II pBR322
DNA fragment. Ice-cold ethanol was added to the samples to
stop the reaction. After preincubation of the DNA fragment
with distamycin A and some intercalators such as ethidium
bromide and Adriamycin at 370C for 30 min, the dynemicin-
induced DNA cleavage was investigated and compared with
the nucleotide sequence cleavage of intact DNA with dyne-
micin. DNAs modified with aflatoxin B1 (9), cis-diammine-
dichloroplatinum (10), and anthramycin (11) were prepared.
Electrophoresis was performed on a 10% polyacrylamide/7
M urea slab gel, and DNA sequencing was carried out by the
Maxam-Gilbert method (12). The autoradiograms were
scanned with a laser densitometer (LKB model 2222 Ultro-
Scan XL).
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RESULTS
Sequence-Specific DNA Cleavage by Dynemicin. Agarose
gel electrophoretic results for dynemicin-mediated strand
scission demonstrated that NADPH, 4-hydroxythiophenol,
or dithiothreitol stimulated DNA cleavage by dynemicin.
Whereas ascorbic acid, sodium dithionite, or sodium boro-
hydride had only a weak effect on dynemicin-mediated DNA
breakage. With 4-hydroxythiophenol or dithiothreitol, form I
DNA was converted to form II and form III DNAs within 30
min. Although the cleavage reaction was slow in the NADPH
system, extensive fragmentation of DNA was clearly ob-
served after 5 hr. Cleavage data for both strands (DNA
fragments 32P-labeled at both ends) in the dynemicin-
NADPH system are presented in Fig. 2. In this experiment,
the Sal I-Dra II fragment (128 bp) was used as DNA
substrate. As shown in the histogram (Fig. 3), (i) dynemicin
preferentially attacks the 3' side of purine bases such as
5'-AG, 5'-GC, and 5'-AI and (ii) among the four bases
guanine is a relatively favorable cutting site for dynemicin. In
addition, the drug appears to cause typical double-strand cuts
at the sequence
3'-GATGATGACC
5'-CTACTACTGG.
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FIG. 3. Histograms of DNA-cutting sites by dynemicin for intact
DNA and actinomycin D (AMD)- or distamycin A (DMC)-pretreated
DNA. Relative DNA cleavage frequencies were obtained from
densitometric scans of autoradiograms from gels.
Alteration of Dynemicin-Induced DNA Cleavage by Pre-
treatment ofDNA with Groove Binders and Intercalators. Fig.
4 shows DNA fragments generated by dynemicin after pre-
treatment with ethidium bromide, proflavine, Adriamycin,
actinomycin D, anthramycin, and distamycin A. These pat-
terns were compared with the standard nucleotide-specific
cleavage products for intact DNA in the dynemicin-NADPH
system. Inhibition of the dynemicin-induced DNA cleavage
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FIG. 2. Strand scission of 5'-end-labeled (lanes 1-3) and 3'-
end-labeled (lanes 4-6) DNA sequences by dynemicin. Lanes 3 and
4 show DNA cleavage patterns by dynemicin (50 ,uM) and NADPH
(5 mM) at 37°C for 5 hr. Lanes 1 and 6 show intact DNA. Lanes 2 and
5 indicate the Maxam-Gilbert sequencing reaction for G+A.
by Adriamycin was considerably greater than by ethidium
bromide or proflavine. Actinomycin D also masked some
dynemicin cutting sites such as 5'-GC. In addition, as in lane
6, cleavage at certain nucleotides was appreciably enhanced
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FIG. 4. DNA-cutting modes by dynemicin after pretreatment
with ethidium bromide (lane 3), proflavine (lane 4), Adriamycin (lane
5), actinomycin D (lane 6), anthramycin (lane 8), or distamycin A
(lane 9). After the pretreatment of the DNA fragment with these
compounds (50 ALM) at 37°C for 30 min, the DNA cleavage reactions
were carried out by dynemicin (50 ,uM) and NADPH (5 mM) at 37°C
for 5 hr. Lane 7 shows dynemicin-induced DNA cleavage for intact
DNA. Lanes 1 and 2 show intact DNA and the Maxam-Gilbert
sequencing reaction for G+A, respectively.
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FIG. 5. Cleavage sites ofG4 gene F/G space DNA fragments by dynemicin. Arrows indicate the cleavage sites and their thicknesses reflect
the relative intensity of the band on the autoradiograms.
by pretreatment with actinomycin D. Preincubation of the
DNA fragment with distamycin A, which is a typical minor
groove binder, caused strong inhibition ofDNA strand scis-
sion by dynemicin near A+T-rich regions. The effects of
actinomycin D and distamycin A on the dynemicin-induced
DNA cleavage are summarized in Fig. 3. In another DNA
fragment (EcoRI-Dde I), the original cutting sites in A+T-
rich regions, such as TTIATC-5' and CIGTAA-5', were also
depressed by pretreatment with distamycin A, an AT-
preferential minor groove binder. Furthermore, modification
of the guanine 2-amino group with anthramycin inhibited
DNA cleavage by dynemicin. Inhibition ofanthramycin (lane
8) was approximately equivalent to that of Adriamycin (lane
5). In contrast, similar covalent attachment of aflatoxin B1 to
the N-7 ofguanine gave no obvious inhibition or alteration of
the dynemicin-induced DNA cleavage. Similarly, modifica-
tion at the N-7 ofguanine with cis-diamminedichloroplatinum
also 'did not significantly affect DNA strand scission by
dynemicin (data not shown). It should be noted that the
2-amino group and the N-7 atom ofguanine are situated in the
minor and major grooves of the DNA duplex, respectively.
Cleavage of Stem-and-Loop Structures in DNA by Dynemi-
cin. To investigate the dynemicin cleavage of DNA that is
able to form secondary and tertiary structures, we used
single-stranded and double-stranded DNA substrates derived
from the phage G4 origin ofcomplementary-strand synthesis.
Fig. 5 summarizes sequence-specific dynemicin cleavage of
the single-stranded and double-stranded DNA substrates.
Some of the preferred cutting sites in double-stranded DNA
were clearly resistant to cleavage in single-stranded DNA. In
single-stranded DNA, the preferred sites of dynemicin-
induced DNA cleavage lay primarily on the inverted repeat
sequences. Most of the strong cutting sites by dynemicin for
these substrates were at the dinucleotide sequences 5'-AT
and 5'-GT. A certain bulge thymine was also a preferred
cleavage site in double-stranded DNA.
DISCUSSION
Dynemicin has potent DNA breakage activity in the presence
of thiol compounds, as do esperamicin and calicheamicin
(2-5). In addition, one characteristic of DNA cleavage me-
diated by dynemicin that is shared with esperamicin and
calicheamicin is cleavage induction by NADPH. In analogy
with other enediyne antibiotics such as esperamicin, dyne-
micin was irreversibly inactivated by preincubation with
dithiothreitol or 4-hydroxythiophenol. Indeed, a dynemicin
derivative (Fig. 1), which was prepared by treatment of
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dynemicin with HCI causing aromatization of the enediyne
structure, had no DNA cleavage activity under the experi-
mental conditions used with dynemicin. This result strongly
indicates that the enediyne chromophore significantly con-
tributes to the present DNA strand scission. Presumably, a
phenylene diradical produced by cyclization of the diyne-ene
is the active form of dynemicin, similar to the mechanism
proposed for compounds in this class of antitumor agents
responsible for potent DNA breakage (2, 4, 13, 14). For
dynemicin, opening the epoxide appears to be the key in
activation to the diaryl radical form of dynemicin-namely,
the DNA-cleaving intermediate. A more reasonable mecha-
nism for the epoxide ring opening reaction requires the
conversion of dynemicin by a one-electron reduction or two
sequential one-electron reductions to the hydroquinone. The
quinone methide formed can undergo nucleophilic attack by
water or act as nucleophile and become protonated giving the
hydroquinonediol or the quinone alcohol, respectively (15,
16). The compounds can then undergo the Bergman reaction
and aromatize (Fig. 6). The blocking ofDNA damage by high
levels of thiols and the detection of free radical signals in a
preliminary ESR study suggest a radical mechanism for the
action of dynemicin. However, dynemicin-mediated strand
scission frequently occurs at guanines and adenines. The
bases adenine and guanine are particularly susceptible to
alkylation that could result in cleavage at these sites without
invoking the presence of radicals. Perhaps dynemicin takes
advantage of both alkylation and hydrogen atom abstraction
to effect DNA cleavage. In the presence of thiol cofactors,
dynemicin at concentrations as low as 0.5 ,uM causes DNA
cleavage in supercoiled pBR322 DNA. Calicheamicin and
esperamicin appear to be more efficient at generating DNA
strand breaks.
Although the DNA damage by dynemicin is not particu-
larly base-specific, dynemicin does preferentially attack
bases adjacent to the 3' side of purines such as 5'-GC, 5'-GT,
5'-AT, and 5'-AG. Among the four bases, guanine is a
favored cutting site for dynemicin. It is of interest that this
base is the most resistant to cleavage by esperamicin (3),
calicheamicin (4), and neocarzinostatin (5). The cleavage
mode ofdynemicin clearly differs from that ofesperamicin (3)
and calicheamicin (4), which show preferential cytosine and
thymine cutting in oligopyrimidine regions. As shown in the
autoradiograms (Figs. 2 and 4), the radioactive bands pro-
duced by dynemicin were found to be electrophoretically
identical to the Maxam-Gilbert products (12), suggesting the
presence of 3'-phosphates at the present DNA breaks. When
the cleavage products were treated with base, the products
coincidently migrated with the sequencing markers in this
DNA fragment. It is also observed that dynemicin occasion-
ally caused strong strand breaks 3 bp apart in the two DNA
strands (for example, the 5'-CTACTACTGG and its comple-
ment 3'-_jATjATjACC). This cleavage pattern is well-
known for DNA damage by calicheamicin (4) and espera-
micin (3). This cutting mode is characteristic of double-
stranded DNA breakage. Furthermore, the asymmetric
cleavage pattern on the 3' side of opposite strands suggests
interaction of dynemicin with the minor groove of the DNA
helix (17). Indeed, the nucleotide cleavage pattern generated
by dynemicin is significantly affected by pretreatment of the
DNA with distamycin A and anthramycin, strongly support-
ing an interaction between the minor groove of DNA and
dynemicin. Distamycin A is a well-known minor groove
binder and anthramycin is a typical modifier of the guanine
2-amino group. In contrast, the covalent attachment of afla-
toxin B1 or cis-diamminedichloroplatinum to the guanine N-7
atom, which is situated in the major groove ofDNA, does not
generate changes in the dynemicin cleavage pattern. On the
other hand, Adriamycin and actinomycin D strongly inhibited
dynemicin-induced DNA cleavage. This suggests that these
drugs disturb sites of dynemicin-DNA interaction by inter-
calating between purine bases. In the EcoRI-Dde I and Sal
I-Dra II pBR322 DNA fragments, repeated DNase I cleaving
inhibition analyses did not show a large number of distinct
footprints for DNA complexed to dynemicin but did show
certain weak footprints of approximately 2 bp, such as 5'-GC
and 5'-AT. The sequence-preferred DNA binding sites of
several anthraquinone-base intercalating drugs, including
mitoxantrone, which were revealed by DNase I footprinting
have been reported to be 5'-purine-pyrimidine sites, such as
5'-GC, -AC, and -AT (18). On the basis of the present results
and a similar anthraquinone core in dynemicin, therefore, this
drug is likely to bind to DNA by intercalating or stacking with
at least one purine base.
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FIG. 6. Model for the mechanism of DNA breakage by dynemicin.
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Fig. 5 shows possible secondary structures near the G4
origin of complementary-strand synthesis (19) and some
interesting features of dynemicin cutting, although the sec-
ondary structure ofDNA is not unequivocally clarified. Most
of the preferred cleavage sites are in stem regions of the
single-stranded DNA, indicating that dynemicin does not
bind efficiently to single-stranded DNA. The loop regions in
the double-stranded and single-stranded DNAs were also
resistant to the dynemicin-induced cleavage, although the
single-stranded DNA was cleaved at certain bases that lie
outside the inverted repeat sequences. This suggests that the
site preferred by dynemicin may form a stem-and-loop struc-
ture. Therefore, dynemicin appears to be a probe for stem-
and-loop structures. It should be noted that dynemicin pref-
erentially cleaved DNA at the predicted stem regions [in-
verted repeat DNA sequences that potentially form stem-
and-loop structure have often been found at regulatory sites
such as operator and transcription termination regions and
DNA replication origin (20-22)].
In conclusion, dynemicin is a unique hybrid of an an-
thraquinone and a 1,5-diyn-3-ene that shows potent DNA
cleavage activity in the presence of NADPH and dithiothrei-
tol. Preferred cleavage sites in dynemicin-mediated DNA
degradation are at bases adjacent to the 3' side of purines
such as 5'-GC, 5'-GT, 5'-AT, and 5'-AG, and the present
nucleotide sequence cleavage mode clearly differs from those
of other enediyne antibiotics, such as esperamicin and cali-
cheamicin. The strong inhibition of the dynemicin-induced
DNA cutting by distamycin A and anthramycin indicates a
minor groove interaction of B-DNA with dynemicin. In
addition, dynemicin appears to bind intercalatively to DNA
through its anthraquinone core. Indeed, the double-stranded
DNA and the stem regions of single-stranded DNA are good
substrates for the dynemicin-induced DNA strand scission.
The proposed mechanism of action most likely involves
phenyl diradical formation similar to that involved in DNA
strand cleavage by esperamicin, calicheamicin, and neocarzi-
nostatin.
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